← All companies
VRTX
Vertex Pharmaceuticals Incorporated
$487.71
+9.00 +1.88%
Key statistics
from XBRL data in SEC filingsMarket cap
$124B
Revenue (TTM)
$12.6B
Net income (TTM)
$4.41B
EPS (TTM)
$17.17
P/E ratio
28.4
Dividend yield
—
Free cash flow
$3.19B
Cash
$6.14B
Total assets
$27.4B
Gross margin
—
52-week range
$362.50 – $533.67
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Aug 4, 2026
8-K
Results of operations (earnings release)
Aug 3, 2026
8-K
Entered a material agreement; Regulation FD disclosure; Other events
Jul 7, 2026
8-K
Director or officer change; Shareholder vote results
May 13, 2026
10-Q
Quarter ended 2026-03-31
May 5, 2026
8-K
Results of operations (earnings release)
May 4, 2026
8-K
Director or officer change
Apr 29, 2026
8-K
Other events
Mar 31, 2026
10-K
Fiscal year ended 2025-12-31
Feb 13, 2026
8-K
Results of operations (earnings release)
Feb 12, 2026
10-Q
Quarter ended 2025-09-30
Nov 4, 2025
8-K
Results of operations (earnings release)
Nov 3, 2025
10-Q
Quarter ended 2025-06-30
Aug 5, 2025
8-K
Results of operations (earnings release); Director or officer change
Aug 4, 2025
8-K
Other events
May 19, 2025
8-K
Shareholder vote results
May 14, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release)
May 5, 2025
8-K
Other events
Mar 28, 2025
10-K
Fiscal year ended 2024-12-31
Feb 13, 2025
8-K
Results of operations (earnings release); Director or officer change
Feb 10, 2025
8-K
Regulation FD disclosure
Dec 20, 2024
10-Q
Quarter ended 2024-09-30
Nov 5, 2024
8-K
Results of operations (earnings release)
Nov 4, 2024
8-K
Entered a material agreement
Aug 16, 2024
10-Q
Quarter ended 2024-06-30
Aug 2, 2024
8-K
Results of operations (earnings release)
Aug 1, 2024
8-K
Other events
Jun 27, 2024
8-K
Other events
May 20, 2024
8-K
Shareholder vote results
May 15, 2024
10-Q
Quarter ended 2024-03-31
May 7, 2024
8-K
Results of operations (earnings release)
May 6, 2024
8-K
Entered a material agreement; Other events
Apr 11, 2024
10-K
Fiscal year ended 2023-12-31
Feb 15, 2024
8-K
Results of operations (earnings release)
Feb 5, 2024
8-K
Other events
Dec 8, 2023
8-K
Director or officer change
Dec 5, 2023
10-Q
Quarter ended 2023-09-30
Nov 7, 2023
8-K
Results of operations (earnings release)
Nov 6, 2023
8-K
Director or officer change
Oct 5, 2023